ad

Gujarat Kidney IPO Listing Preview: What to Expect Now?

Fri Dec 26 2025

Gujarat Kidney IPO Listing Preview: What to Expect Now?

The Gujarat Kidney Limited listing is scheduled for 30th December 2025. The IPO was opened for bidding from 22nd December 2025 to 24th December 2025. It is a bookbuilding IPO of ₹250.80 crores, comprising a fresh issue of 2.20 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 30th December 2025. Scroll down to know more about Gujarat Kidney IPO listing expectations.

Gujarat Kidney IPO Listing Preview

As per the recent updates, the IPO listing of Gujarat Kidney could be at around ₹114 per share on 30th December 2025. This conclusion is based on the Gujarat Kidney GMP (grey market premium). However, the GMP and expected listing price are subject to change based on market sentiment. Stay informed with Univest to get live updates on the Complex Cinemas IPO listing or GMP trends. Scroll to explore the GMP of the Gujarat Kidney IPO.

Gujarat Kidney IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Gujarat Kidney  IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

GMP DATEIPO PriceGMP PriceEstimated Listing PriceEstimated Gain
26-12-2025₹114.00₹0.00₹114.000.00%
25-12-2025₹114.00₹0.00₹114.000.00%
24-12-2025₹114.00₹0.00₹114.000.00%
23-12-2025₹114.00₹3.50₹117.503.07%
22-12-2025₹114.00₹4.00₹118.003.51%
21-12-2025₹114.00₹7.00₹121.006.14%
20-12-2025₹114.00₹7.00₹121.006.14%
19-12-2025₹114.00₹7.00₹121.006.14%
18-12-2025₹114.00₹10.00₹124.008.77%
17-12-2025₹114.00₹0.00₹86.000.00%
16-12-2025₹114.00₹0.00₹86.000.00%
15-12-2025₹114.00₹0.00₹86.000.00%

As of 26th December 2025, the Gujarat Kidney IPO GMP stands at ₹0 per share. This means shares are likely to list at ₹114 on their tentative listing date, 30th December 2025.

GMP data is subject to change based on market conditions. You should check the live GMP status before applying for the Gujarat Kidney IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends.

Gujarat Kidney & Super Speciality Limited Financials

The company’s financial analysis is essential before applying for the Gujarat Kidney & Super Speciality IPO. Look at the table to learn about Gujarat Kidney & Super Speciality Limited’s financials. 

Year Ended30th June 2025 (in cr.)31st March 2025 (in cr.)31st March 202431st March 2023
Assets61.5955.3420.533.87
Revenue15.2740.405.480.00
Profit After Tax5.409.501.71-0.01
EBITDA8.6316.551.95-0.01
Net Worth30.5625.7110.800.37
Reserves and Surplus19.4214.5710.600.17
Total Borrowings4.033.881.94

Explanation

Gujarat Kidney & Super Speciality Limited’s revenue increased by 637% from ₹5.48 crores in March 2024  to ₹40.40 crores in March 2025. Moreover, the company’s PAT increased by 454% from ₹1.71 crores in March 2024 to ₹9.50 crores in March 2025.

How to Check Gujarat Kidney & Super Speciality IPO Allotment Status?

Gujarat Kidney & Super Speciality IPO Allotment Status

You can check for the Gujarat Kidney & Super Speciality IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On NSE

  • Visit the NSE Official Site
  • Navigate to the IPO Allotment Section. 
  • Select Equity as the issue type. 
  • Choose the Gujarat Kidney & Super Speciality IPO.  
  • Choose whether to proceed with the PAN number or the application number.
  • Submit your details to get the allotment status online. 

Check On the Registrar Portal

  • Visit the registrar portal.
  • Click on the allotment option.
  • Fill in the required details.
  • Click on the submit button to know your Gujarat Kidney & Super Speciality IPO allotment status.

Recent Articles

HBL Engineering Q1 Results FY26: Q1 PAT Rises 78.87% to ₹143.27 Crore; Revenue Up 15.70% YoY

Fine Organic Q1 Results FY26: Q1 PAT Rose 7.04% to ₹117.10 Crore; Revenue Up 7.04% YoY

Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY

JM Financial Q1 Results FY26: Q1 PAT Rose 165.85% to ₹453.81 Crore; Revenue Up 3.18% YoY

IPCA Laboratories Q1 Results FY26: Q1 PAT Rises 21.31% to ₹233.21 Crore; Revenue Up 10.33% YoY